KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Riad Sherif, MD, CEO of Oculis, discusses data on OCS-05 for the treatment of acute optic neuritis. “The main goal of OCS-05 is to prevent retinal ganglion cells from dying and to have a neuroprotective effect,” he said. “We are extremely happy to see that OCS-05 showed improvement in anatomy and